Carlyle and Brighton Park agree to invest $200m in Indegene

Carlyle and Brighton Park agree to invest $200m in Indegene

The Carlyle Group and Brighton Park Capital are to acquire minority stakes in Indegene, a Bangalore-headquartered enterprise healthtech solutions provider, for USD200 million. The transaction, which is subject to customary regulatory approvals, consists of a secondary...